NewsTop Stories
Aussie vaccine technology ‘promising’ but risks to COVID-19 strategy were too great: study
Australia’s homegrown COVID-19 vaccine candidate had potential but the false positives on HIV tests were too great a hurdle to move it into further trials, a study published this week has confirmed.
Please login below to view content or subscribe now.
